Role of Defective Interfering Particles in Complement-Mediated Lysis of Parainfluenza Virus-Infected Cells., PMID:40284931
A region of mumps virus nucleoprotein affects defective interfering particle production., PMID:40214656
The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1., PMID:40146622
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates., PMID:40116506
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants., PMID:40116505
Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells is acquired after transition from acute to persistent infection., PMID:39791880
Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody., PMID:39786361
Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infections., PMID:39264707
Parainfluenza Virus 5 V Protein Blocks Interferon Gamma-Mediated Upregulation of NK Cell Inhibitory Ligands and Improves NK Cell Killing of Neuroblastoma Cells., PMID:39205244
Isolation, genome analysis and comparison of a novel parainfluenza virus 5 from a Siberian tiger (Panthera tigris)., PMID:38686028
Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer., PMID:38395933
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year., PMID:38360853
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses., PMID:38305155
Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study., PMID:37878713
PCR-Based Detection and Genetic Characterization of Parainfluenza Virus 5 Detected in Pigs in Korea from 2016 to 2018., PMID:37505820
A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice., PMID:37503102
Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus-Receptor Interactions., PMID:37446852
CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection., PMID:36016357
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants., PMID:35702147
A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells., PMID:35373581
Characterization of parainfluenza virus 5 from diarrheic piglet highlights its zoonotic potential., PMID:35179303
Complement Inhibitors Vitronectin and Clusterin Are Recruited from Human Serum to the Surface of Coronavirus OC43-Infected Lung Cells through Antibody-Dependent Mechanisms., PMID:35062233
Paramyxovirus-Like Particles as Protein Delivery Vehicles., PMID:34379508
Rescue of dual reporter-tagged parainfluenza virus 5 as tool for rapid screening of antivirals in vitro., PMID:34237497
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine., PMID:34215591
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity., PMID:34209034
Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates., PMID:33717130
Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA., PMID:33352107
A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine., PMID:33039727
The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Burkholderia mallei and provides protection against lethal aerosol challenge., PMID:32799724
Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5., PMID:32295916
Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection., PMID:32265331
Parainfluenza virus 5 fusion protein maintains pre-fusion stability but not fusogenic activity following mutation of a transmembrane leucine/isoleucine domain., PMID:32100701
Common and unique mechanisms of filamentous actin formation by viruses of the genus Orthorubulavirus., PMID:32100137
Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation., PMID:32075920
Parainfluenza Virus 5 Infection in Neurological Disease and Encephalitis of Cattle., PMID:31941046
Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses., PMID:31896588
A Hydrophobic Target: Using the Paramyxovirus Fusion Protein Transmembrane Domain To Modulate Fusion Protein Stability., PMID:31217248
Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection., PMID:31010715
The switch between acute and persistent paramyxovirus infection caused by single amino acid substitutions in the RNA polymerase P subunit., PMID:30742688
Angiomotin-Like 1 Links Paramyxovirus M Proteins to NEDD4 Family Ubiquitin Ligases., PMID:30708959
The autotransporter protein BatA is a protective antigen against lethal aerosol infection with Burkholderia mallei and Burkholderia pseudomallei., PMID:33826684
Alston Virus, a Novel Paramyxovirus Isolated from Bats Causes Upper Respiratory Tract Infection in Experimentally Challenged Ferrets., PMID:30487438
Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization., PMID:29693588
The Hemagglutinin-Neuraminidase (HN) Head Domain and the Fusion (F) Protein Stalk Domain of the Parainfluenza Viruses Affect the Specificity of the HN-F Interaction., PMID:29593671
Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy., PMID:29343567
Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine., PMID:29263887
Structure of the Paramyxovirus Parainfluenza Virus 5 Nucleoprotein in Complex with an Amino-Terminal Peptide of the Phosphoprotein., PMID:29237836
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge., PMID:28931689
Human parainfluenza virus type 2 polymerase complex recognizes leader promoters of other species belonging to the genus Rubulavirus., PMID:28884293
For research use only. Not for human or drug use.
